Dr. Jagat R. Kanwar
Deakin University,
Australia
Email: jagat.kanwar@deakin.edu.au
Qualifications
1993 Ph.D.,
Molecular Immunology & Biotechnology, Postgraduate Institute of edical
Education & Research, Chandigarh, India
1988 M.Sc., Medical
Biotechnology, Punjab Agricultural University, Ludhiana, India
1984 B.Sc., Medical
Sciences, Himachal Pradesh University, Shimla, India
Publications(Selected)
-
Jagat R. Kanwar,
Mahidhara Ganesh and Rupinder K Kanwar. (2011) Anti-angiogenic therapy using
nanotechnological based delivery system, Drug Discovery Today, 2011
Mar;16(5-6):188-202. IF: - 6.63, Top 5% in the field, Journal class: -A
-
MohantyChandana, Das
Manasi, Jagat R. Kanwar and Sanjeeb K. Sahoo. (2011) Receptor mediated tumor
targeting : an emerging approach for cancer therapy, Current Drug Delivery,
1/01/2011, 8(1): 45-58, IF:- 4.9
-
Shu-Ming He, Songshu
Li, Jagat R. Kanwar and Shu-Feng Zhou. (2011) Structural and functional
properties of human multidrug resistance protein 1 (MRP1/ABCC1), Current
Medicinal Chemistry, in press 2011, 18, IF: - 4.9, Journal class: -B
-
E. Giuliano, B. W.
Yarnall, R. Gupta, B. Dylan, J. R. Kanwar. (2011) Mitomycin C: A promising
agent for the treatment of canine corneal scarring, Veterinary Ophthalmology,
In Press. IF: - 1.516. Journal class:- B
-
H. Burrow, R. K.
Kanwar, J. R. Kanwar (2011) Design antioxidant enzyme activities of iron
saturated bovine lactoferrin (Fe-blf) in human gut epithelial HT29 cells under
oxidative stress, Medicinal Chemistry, In Press. IF: - 2.82. Journal class: -B
-
J. R. Kanwar, Neha
Singh, and R. K. Kanwar. (2011) Role of nanomedicine in reversing drug
resistance mediated by ATP binding cassette transporters and p-glycoprotein in
melanoma. Nanomedicine London UK. 2011 6(4): 701-714. IF:- 5.982, Top 5% in the
field
-
Jagat R. Kanwar,
Rajiv R. Mohan, Kanwar, K. Rupinder, Kislay Roy and Raj Bawa. (2010)
Applications of aptamers in nanodelivery systems in cancer, eye and
inflammatory diseases, Nanomedicine, 2010, 5(9): 1435-1445, IF:- 5.982, Top 5%
in the field
-
Liam Matthews,
Rupinder K. Kanwar, Shufeng Zhou, VasuPunj and Jagat R. Kanwar. (2010)
Applications of nanomedicine in antibacterial medical therapeutics and
diagnostics. Open Tropical Medicine Journal, 2010, 3(1)
-
Gibbons, Rupinder K.
Kanwar and Jagat R. Kanwar. (2010) Effect of Bovine Lactoferrin on different
Cancer Models. Frontiers in Bioscience, In Press. IF: - 3.063
-
Jagat R. Kanwar,
Ganesh Mahidhara and Rupinder K. Kanwar. (2010) MicroRNA in human cancer and
chronic inflammatory diseases, Frontiers in Bioscience (scholar edition),
1/06/2010, 9: 1113-1126, IF:- 3.063
-
Lixin Ma,
HaiquanQiao, Changjun He, Qian Yang, Hei Antonio Chun Cheung, Jagat R. Kanwar
and Xueying Sun. (2010) Modulating the interaction of CXCR4 and CXCL12 by
low-molecular-weight heparin inhibits hepatic metastasis of colon cancer.
Investigational New Drugs, online first 2010-11-15, IF:- 3.396
-
RangamRajkhowa,
Lijing Wang, Jagat R. Kanwar and Xungai Wang. (2010) Molecular weight and
secondary structure change in eri silk during alkali degumming and powdering,
Journal of Applied Polymer Science, 2010, 119(3): 1339-1347, IF:- 1.187,
Journal class: -B
-
Sara Baratchi,
Rupinder K. Kanwar, Chun Hei Antonio Cheung and Jagat R. Kanwar. (2010)
Proliferative and protective effects of SurR9-C84A on differentiated neural
cells. Journal of Neuroimmunology, 8/10/2010, 227(1): 120-132, IF:- 2.841.
Journal class:- B.Page 11 of 26
-
R. K. Kanwar, C. H.
Cheung, J. Y. Chang and J. R. Kanwar. (2010) Recent advances in anti-survivin
treatments for cancer. Current Medicinal Chemistry, 1/05/2010, 17(15):
1509-1515, IF:- 4.9. Journal class: -B
-
Alicia Wynne,
Rupinder K. Kanwar, Rajiv Khanna and Jagat R. Kanwar. (2010) Recent advances on
the possible neuroprotective activities of Epstein-Barr virus oncogene BARF1
protein in chronic inflammatory disorders of central nervous system.
Current Neuropharmacology, 2010-09, 8(3): 268-275, IF:- 1.731. Journal class: -B